[Cimetidine versus ranitidine in the treatment of peptic esophagitis]. 1983

G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli

A double blind test with cimetidine and ranitidine conducted on 60 patients with acid reflux oesophagitis revealed cimetidine to be the more effective. Its success is felt to lie more in the drug's ability to activate defensive factors than in its inhibition of acid secretion.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004942 Esophagitis, Peptic INFLAMMATION of the ESOPHAGUS that is caused by the reflux of GASTRIC JUICE with contents of the STOMACH and DUODENUM. Esophagitis, Reflux,Esophagitides, Peptic,Esophagitides, Reflux,Peptic Esophagitides,Peptic Esophagitis,Reflux Esophagitides,Reflux Esophagitis
D005260 Female Females
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2

Related Publications

G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
January 1996, Clinical therapeutics,
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
August 1984, Zeitschrift fur Gastroenterologie,
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
November 1977, Gaceta medica de Mexico,
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
July 1982, Drug and therapeutics bulletin,
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
January 1985, Lancet (London, England),
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
May 1992, Annals of Saudi medicine,
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
June 1988, Hepato-gastroenterology,
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
September 1986, Deutsche medizinische Wochenschrift (1946),
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
January 1986, Sovetskaia meditsina,
G Noya, and G Dettori, and A Muscas, and R Spirito, and P Niolu, and G Marongiu, and P Biglioli
May 1992, Annals of Saudi medicine,
Copied contents to your clipboard!